Search research articles
Contact Us
Filters
Showing results (81-90 of 89) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 89 results.
Wellcome Open Research
|
June 10, 2024
Integrated management of cryptococcal meningitis and concurrent opportunistic infections to improve outcomes in advanced HIV disease: a randomised strategy trial
Jayne Ellis, Laura Nsangi, Ananta Bangdiwala, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 4, 2009
Randomized phase III trial of gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response prediction in non-small-cell lung cancer
Craig Reynolds, Coleman Obasaju, Michael J Schell, et al.
Leukemia & Lymphoma
|
October 27, 2022
Frontline treatment approaches in <i>TP53</i>-aberrant mantle cell lymphoma
Nikesh N Shah, Franco Castillo-Tokumori, Junmin Whiting, et al.
Diabetes Care
|
September 28, 2019
Who Is Enrolling? The Path to Monitoring in Type 1 Diabetes TrialNet's Pathway to Prevention
Emily K Sims, Susan Geyer, Suzanne Bennett Johnson, et al.
Diabetes Care
|
March 6, 2020
Erratum. Who Is Enrolling? The Path to Monitoring in Type 1 Diabetes TrialNet's Pathway to Prevention. Diabetes Care 2019;42:2228-2236
Emily K Sims, Susan Geyer, Suzanne Bennett Johnson, et al.
Southern African Journal of HIV Medicine
|
September 15, 2021
Establishing targets for advanced HIV disease: A call to action
David B Meya, Lillian Tugume, Vennie Nabitaka, et al.
Southern African Journal of HIV Medicine
|
March 24, 2020
Southern African HIV Clinicians Society guideline for the prevention, diagnosis and management of cryptococcal disease among HIV-infected persons: 2019 update
Nelesh P Govender, Graeme Meintjes, Phetho Mangena, et al.
Journal of the American College of Surgeons
|
December 14, 2020
Surveillance of Sentinel Node-Positive Melanoma Patients with Reasons for Exclusion from MSLT-II: Multi-Institutional Propensity Score Matched Analysis
Kristy K Broman, Tasha M Hughes, Lesly A Dossett, et al.
Emerging Infectious Diseases
|
March 21, 2026
New 2030 Global Targets for Histoplasmosis from International Society for Human and Animal Mycology (ISHAM) 2025 Histoplasmosis Working Group
Alessandro C Pasqualotto, David W Denning, Thuy Le, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 89) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 89 results.
Wellcome Open Research
|
June 10, 2024
Integrated management of cryptococcal meningitis and concurrent opportunistic infections to improve outcomes in advanced HIV disease: a randomised strategy trial
Jayne Ellis, Laura Nsangi, Ananta Bangdiwala, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 4, 2009
Randomized phase III trial of gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response prediction in non-small-cell lung cancer
Craig Reynolds, Coleman Obasaju, Michael J Schell, et al.
Leukemia & Lymphoma
|
October 27, 2022
Frontline treatment approaches in <i>TP53</i>-aberrant mantle cell lymphoma
Nikesh N Shah, Franco Castillo-Tokumori, Junmin Whiting, et al.
Diabetes Care
|
September 28, 2019
Who Is Enrolling? The Path to Monitoring in Type 1 Diabetes TrialNet's Pathway to Prevention
Emily K Sims, Susan Geyer, Suzanne Bennett Johnson, et al.
Diabetes Care
|
March 6, 2020
Erratum. Who Is Enrolling? The Path to Monitoring in Type 1 Diabetes TrialNet's Pathway to Prevention. Diabetes Care 2019;42:2228-2236
Emily K Sims, Susan Geyer, Suzanne Bennett Johnson, et al.
Southern African Journal of HIV Medicine
|
September 15, 2021
Establishing targets for advanced HIV disease: A call to action
David B Meya, Lillian Tugume, Vennie Nabitaka, et al.
Southern African Journal of HIV Medicine
|
March 24, 2020
Southern African HIV Clinicians Society guideline for the prevention, diagnosis and management of cryptococcal disease among HIV-infected persons: 2019 update
Nelesh P Govender, Graeme Meintjes, Phetho Mangena, et al.
Journal of the American College of Surgeons
|
December 14, 2020
Surveillance of Sentinel Node-Positive Melanoma Patients with Reasons for Exclusion from MSLT-II: Multi-Institutional Propensity Score Matched Analysis
Kristy K Broman, Tasha M Hughes, Lesly A Dossett, et al.
Emerging Infectious Diseases
|
March 21, 2026
New 2030 Global Targets for Histoplasmosis from International Society for Human and Animal Mycology (ISHAM) 2025 Histoplasmosis Working Group
Alessandro C Pasqualotto, David W Denning, Thuy Le, et al.
Page
of 9